health
Six-site RNA signature distinguishes a ReNU syndrome variant in preprint study
A medRxiv preprint describes a six-site RNA-splicing signature that distinguished 19 people with a specific RNU4-2 variant from study controls. The researchers propose it as a biomarker for therapeutic development, with results so far focused on T-loop variants.